Fig 4. Odds ratio (OR) with 95% confidence interval (CI) of NMA for bone fracture events based on a frequentist framework.

Note: Treatments were reported in alphabetical order. Results of direct comparisons were listed in the upper triangle, and the estimation was calculated as the row-defining treatment compared with the column-defining treatment. Results of NMA were listed in the lower triangle, and the estimation was calculated as the column-defining treatment compared with the row-defining treatment. NA: not available. GLP-1RAs (Glucagon-like peptide-1) receptor agonists; SGLT-2: Sodium-Glucose co-Transporter 2; Met: metformin; SU: sulphanylureas; TZDs: thiazolidinediones.